1058
KLINICKÁ341804301074588109168189242288347
FARMAKOLOGIE708804301074392139212266313373416475534555599
A13288043010753
FARMACIE1402804301074292139211266317337381
/18048043010757
Klin1880804301077091109157
Farmakol2057804301074278105179220258305325
Farm2402804301074178104179
2023;37(1):10-182601804301074386128172186230270290330348362399439469507546
/31678043010757
www.klinickafarmakologie.cz4568804301076513320121425327329234035839843647950254457164568672477179183988990895196610061045
181878026012657111
HLAVNÍ341207012670127198263336370
TÉMA732207012658115205275
Čo34136501063271
je42736501062355
nové49736501064081118150
vo66236501063776
farmakoterapii75336501062967103158198233272303335371413447464482
benígnej124936501063567109126165206238265
hyperplázie152836501064077113144180215246288322340371
prostaty191436501063469110142175211240279
LITERATÚRA34458001234978134189250318368438498567
1.3437400853649
Gravas4077410834669102135168195
S,6187410833549
Cornu6837410834279102141179
J,8787410832739
Gacci9347410834579112143159
M,11097410835771
et11967410833659
al.1271741083345064
EAU13517410833578121
guidelines1488741083417995134170186202241276304
on18087410833978
management190274108360933438410833973114151212249290313
of6738410834566
non-neurogenic7568410834485126150191228268291331373410450467501
male12748410836599116153
lower14448410832262116152175
urinary1636841083456885125160183219
tract1872841083285186121147
symptoms3439410832659119158181219278305
(LUTS),664941083174992127162181193
incl.873941083135285101114
benign10039410833774112128168206
prostatic1225941083376098125149182205221253
obstruction14949410833676104128150189221246262301340
(BPO).1850941083175490139157169
[cited343104108319496588123163
202252210410833671104140
December67810410834783116151209249286307
15].10011041083366787100
Available111710410834374108124139172212229264
from:13971041083214381140153
https://uroweb.15661041083406287127154168195216253275313364400440453
org/guidelines.3431141083376098125162200216255291307323361397425439
2.34312400853652
Reynolds40912410833772104142181197236262
W,68612410835969
Strand7701241083345577110148187
D.97212410834758
Benign104512410833772110125164202
prostatic12631241083406199125148181203218250
hyperplasia:152912410833969109145166206222254280295327339
etiology,188412410833557731113431341083155392124133
pathophysiology,4911341083366990128166205244274301315353369407446478487
epidemiology,9931341083327086124159216231269285322362393403
and141113410832967106
natural15321341083356788126147179195
history.1742134108335497598135156190200
In:19571341083125062
Partin3431441083356788113128166
A,52414410834054
Dmochowski593144108344103141174212250301328358375
R,98314410833448
Kavoussi10461441083346799137175201228242
L,130414410833043
et136314410833255
al.,1433144108331465972
editors.15201441083337287110147168196209
Campbell174414410833972130169209244260275
–343154108335
Walsh39315410835889104130168
Urology,57715410834364101117156195227237
12th8291541083346489415450491335
ed.9441541083347487
Saunders104615410833366103141180215236264
Elsevier.13251541083334874109141157191213223
2021:3305-3342.156315410833569102133142177210244278300333366401434446
3.34316400853651
Capogrosso40816410834275114153192213251277304342
P,76516410833742
Salonia8221641083346782120159174206
A,104316410834357
Montorsi111516410835695133155192213240255
F.138616410833340
Evaluation14411641083346699114152184206221259298
and175416410833371110
nonsurgical1880164108339771163431741083266283120135166198213
management57117410835485122154192226283317355376
of96117410833453
benign102917410833670108122160197
prostatic12411741083365793119142174195210241
hyperplasia.149717410833464103138158197213244270284316328
In:18401741083124961
Partin191617410833263843431841083223775
A,43318410834459
Dmochowski507184108348107145178216254305332362378
R,90118410833852
Kavoussi96918410833871103141179205232246
L,123118410833448
et129418410833860
al.,1369184108335516476
editors.14611841083377692114151173200213
Campbell169018410834376134173212248263279
–1984184108335
Walsh34319410835789104130168
Urology,52619410834465102118156196228238
12th7791941083346487125
ed.9191941083347487
Saunders102119410833365103141180215236264
Elsevier.13001941083324874109141157191212223
2021:3343-3402.153819410833468101133141176209245277299332367403436448
4.34320400853651
Marenčák40920410835688110144182214247277
J,70120410832537
Mosnárová75420410835594120158190212249281314
A.108320410834257
Súčasné115520410833471103136162200235
možnosti140620410835896125163201228251267
diagnostiky16882041083395486125163202228252267297331
a343214108332
liečby3902141083213671103143174
benígnej58021410834480118133172210246261
hyperplázie85721410834273114149171211227259289305340
prostaty.121221410834466104131154187209243253
Kompendium148121410834078136176212250289305342401
medicíny1897214108363983432241083385385100138169
1.52722410833444
2018:2-15.58622410833468100131143179199230260272
5.34323400853650
Lerner4082341083357091129164186
L,60923410833549
McVary67323410835891127158180214
K,90223410833953
Barry9712341083397293115149
M,113523410835872
et122223410833860
al.12972341083365164
Management137723410835890128161200235292327366387
of177923410834161
lower185523410831957108142164
urinary3432441083375974113145166201
tract5592441083274982114138
symptoms71324410833164123162185222280307
attributed10352441083385984106121161199222256296
to134624410832764
benign142624410834479118133172210
prostatic165224410834465103130153186208223256
hyperplasia:1923244108343743432541083397495135151183210225257269
AUA62725410833982121
guideline7632541083377489128163179194232267
part10452541083377091116
I1176254108313
–1204254108333
initial1253254108312506588103135151
work-up141925410834986108139159198237
and167125410833068107
medical179325410835691131146178211226
management.34326410835790128160199234292327365387400
J758264108324
Urol.79826410834364102118130
2021;206(4):806-817.94426410833468101132141176210245264297315327361397432456492524553559
6.34327400853651
Gravas4092741083426396128161187
S,61127410833143
Palacios-Moreno6702741083326480112144159197224245301339360394433471
J,115627410832234
Thomson120527410833070108166192231269
D,148927410834354
et155927410833153
al.16282741083294557
Understanding1701274108341791181531742012242572953432841083385391130
treatment4882841083254781113134193228266287
response7912841083235884123162201227262
in106828410831856
individual11392841083185695110143159197235267283
profiles143728410834263101118135151185212
of166528410834059
men174028410836095133
with18892841083536991130
prostatic34329410833962100127151185207223256
enlargement6152941083397994127149188224283319358380
at101129410833860
risk10872941083274370100
of120329410834463
progression.128229410834567105146168203230258273312351365
Eur16632941083387698
Urol177729410834971109126
Focus.1918294108339773433041083316995109
2022.46730410833468101136149
In63130410831553
press6993041083396094121148
https://doi.org/10.1016/j.euf.2022.07.004.8623041083385983123150162189209245283299312350371409436469500513543575607638663679692727765784796832866899933946981101410201055109111271140
7.34331400853645
Yu40231410834075
Z,49231410834255
Yan56231410833969107
H,68431410834861
Xu76031410834379
F,85431410833642
et91131410833861
al.9873141083365164
Efficacy1066314108337557390123155188221
and130231410833674113
side14313141083304583118
effects15653141083385776110143167195
of177531410834261
drugs185131410834263102141167
commonly34332410833270131190230270286319
used67832410834471108149
for8433241083246386
the94532410832767103
treatment10653241083275085118141201237277299
of138032410834464
lower146032410832161113149171
urinary16483241083436582121154177212
tract18763241083285084118143
symptoms34333410832760121161184222282310
associated6693341083386593132166182215238272313
with9983341083587497137
benign115133410834581121136177216
prostatic138333410834567106133158191214230263
hyperplasia.166233410834476117154176217234267294310343357
Front3433441083325289127148
Pharmacol.50634410833370102123181213245282298310
2020;11:658.8313441083326699132145175202211246280313327
doi:11733441083357389101
10.3389/fphar.2020.00658.12893441083316275110143177211234253293331363384395430464497531543578614649683717730
8.34335400853652
Zámečník40935410833568125160193230245276
L.70035410832943
Non-neurogenní75835410834280118140179213251272309348383420458473
poruchy12463541083367596134166204234
močení149535410835593125158196211
u1721354108334
mužů.177135410835492120158170
In:19563541083125062
Zámečník34336410833871129164196234249281
et63936410833658
al.,712364108334496275
editors.8023641083367590113150171199212
Moderní103036410835694134168190228243
farmakoterapie12893641083205374133165195233255288310343382397432
v1736364108334
urologii.17853641083396097113151191206221234
Maxdorf.34337410835487119157195216238249
2019:171-185.60837410833468100130143173202235253284315349361
9.34338400853649
Gravas4063841083416294126158184
S,60538410833042
Bach6623841083326596134
T,81138410833038
Drake8643841083426496126159
M,103838410835265
et111838410833153
al.11863841083294456
Treatment12573841083304780112133190225262283
of155538410833554
non-neurogenic1623384108335731111331712052422633003393733433941083375284
male44239410835587102137
LUTS.59439410832971105139152
In:7613941083125062
EAU83839410833073115
guidelines9683941083367388127161177192229264291
on127439410833573
benign136239410833671109124163201
prostatic15783941083365794121144176198213245
hyperplasia.1838394108335661051411623434041083395587113128160173
Arnhem:53240410834162101139174232244
European7914041083336990128167203235273
Association10794041083416995134166181213235250288327
of142140410833757
Urology.149340410834465102118156196228238
2017:1-54.174640410833468100129140169188222257270
10.3434140085366984
Manohar44241410835285123161199231252
Ch,7094141083387688
Nagabhushana81241410834375114146185223261287325357395427
M,125441410835265
Karthikeyan13354141083326687111149164194228259292330
V,168041410833442
et173841410833153
al.18064141083304558
Safety1879414108330638211634342410832255
and41342410832967106
efficacy534424108331496785116149181214
of76342410833554
tamsulosin,83242410831951109135172187225251266303316
alfuzosin11634241083294463101130167194208246
or142442410833456
silodosin1495424108323385391130168194209246
as175742410832955
monotherapy1827424108355931311693434341083226095116149188219
for5784341083225981
LUTS67443410833578112145
in83543410831856
BPH90643410833975119
–1040434108338
a1094434108335
double114443410834280118157173208
blind13674341083435873111150
randomized15334341083245795134172230245275309348
trial.1897434108325466294109122
Cent34344410834074112133
European4924441083326990127167202234272
J780444108324
Urol.81944410834465102118131
2017;70(1):148-153.96544410833468100130139172205225256271283313344380402433463496509
11.3434540085376982
Csikós4424541083528298130169198
E,65645410834560
Horváth73345410835697120157192215255
A,100545410835469
Ács109145410835387116
K,122445410834763
et130445410834670
al.13914541083446175
Treatment148345410834563100133157217254295318
of181845410834970
benign1905454108351893434641083395596135
prostatic49546410834871110138163197220237270
hyperplasia78246410834779121158181222239273301317351
by114946410834981
natural124746410834781104144166201217
drugs.148146410834770110151179193
Molecules.1691464108364104121158192232248285313328
2021;26(23):7141.34347410833468101133141176209228262297314326359392423453463
doi:8214741083387692104
10.3390/molecules26237141.9404741083346678114147180216240296335351386418456471506533567601634669701734765795805
12.3434840085366884
De44148410834682
Nunzio53848410834583121150166204
C,75748410834154
Brassetti8264841083365790117143178201225240
A,108148410834256
Proietti11524841083365794109144166191206
F,137348410833339
et142848410833456
al.15004841083324760
Dutasteride157648410834684106139166189223244260298333
add-on19254841083327134349410833860100138
therapy4964941083195792113146185216
reduces7274941083195292129161195221
detrusor9644941083357092113151178216237
mass121649410835587114140
in137149410831350
patients14374941083366990105140178199227
with16794941083486386124
benign181849410833671109124163201
prostatic3435041083396198125149182204219252
enlargement6105041083397893126147186221279315353375
not100150410834381103
satisfied11205041083316587102129147164199239
with13755041083567294133
alpha-adrenergic15235041083385392131164187219259280314353388410448464496
antagonist3435141083327091124163201240255281304
monotherapy:66251410835694133171193231266287320359391404
a1082514108330
single11275141083243977116131166
center130851410833063102123157178
prospective15015141083375996123162197230254269302336
study.18535141083244785124156166
Neurourol34352410834580117139176214235272288
Urodyn.64752410834364102141173212225
2017;36(8):2096-2100.88752410833569100130140175209228262280292327361396431455486517549585598
13.2138740085366883
Miernik22377410835368103124163178208
A,24607410834054
Gratzke2529741083426497118149180214
Ch.2758741083387689
Current2863741083387496117151189211
treatment3089741083204276108129187223261282
for3386741083175576
benign34787410833772110125164202
prostatic36957410833759962138841083264982104119151
hyperplasia.23048410833869108144165205221253280295327340
Dtsch2659841083456997129167
Arztebl2841841083416393118152191207
Int.306384108315537488
2020;117(49):843-854.31668410833468101135148178206235252285318336348382419451473509543578591
14.2138940085356882
Reynolds2235941083326697135173188226251
W,25019410835463
Cohn25799410833773111148
J.27419410832234
Overactive27899410834477110131163194218232264298
bladder.3101941083365183121159193213223
In:3339941083124961
Partin3414941083326484108123160
A,35899410833751
Dmochowski36559410834299136213810410833169107158185215231
R,238410410833347
Kavoussi24461041083326697135173199225240
L2701104108329
et274510410833254
al.,2814104108330455870
editors.29001041083317186108145166193207
Campbell312210410833770128167206242257272
–3409104108333
Walsh345710410835586102127165
Urology,3637104108342629911515321381141083387080
12th22331141083346487125
ed.23731141083347487
Saunders247511410833366103141180215237264
Elsevier.27541141083334874109141157192213223
2021:2637-2649.299211410833569102133142177210244276295326359396429440
15.21381240085366984
Kreydin22381241083416498130169185223
E,247712410833851
Gomes254412410834988147183210
C,277012410834559
Cruz284412410834667106136
F.299512410833845
Current305512410834683104127161200222
pharmacotherapy329212410834584116138197230262300322361396418451491523
of213813410833757
overactive221013410833769103125158190214229262296
bladder.25211341083395587126165200221232
Int27681341083155374
Braz28581341083355689119
J2992134108324
Urol.303213410834364102118130
2021;47(6):1091-1107.317813410833468101132141175207224257275287317348383415434465493524557563
16.21381440085366985
Lokeshwar223814410833370101135162199250283304
S,255714410833446
Harper26191441083457798138174195
B,282914410833749
Webb289414410835891130170
E,307914410833447
et314114410833557
al.32141441083334861
Epidemiology32901441083347388127162220235273289327367399
and370414410833371110
treatment21381541083214275105126183216253274
modalities242615410835491129160175189211225259284
for27251541083155172
the28121541083185588
management291515410835384121152190224280314351371
of330115410833452
benign336715410833570107121158195
prostatic35771541083355591117139171192206237
hyperplasia.213816410833868108144165205221253279294326339
Transl24931641083325083121147162
Androl267016410834180119140177193
Urol.287816410834465102118131
2019;8(5):529-539.302416410833469100131143179198231250261297330364388422455488499
17.21381740085366876
Marenčák223017410835890111145184216248278
J.252417410832739
Farmakoterapia25791741083356486144176206244266300321354393408440
hyperaktívneho303517410834071111146168201231255271303342377415453
močového350417410836098131168200234272310
mechúra.213818410835792125163201222255268
Klin24211841083355267105
Urol.254118410834465102118131
2022;18(3):268718410833468101136148179210229262279291
(v299418410831849
tlači).30591841083213769101116135146
18.21381940085366985
Horák223919410834887108141171
A.242619410834459
Současná250119410833674112144177204241274
farmakoterapie27901941083225677135168198235257291312345384400434
benigní324019410834278116131170208223
hyperplazie347819410834272112148169209225257286302337
prostaty21382041083396097124147180202236
dle23892041083385388
doporučení249320410833876115154176214246280318333
EAU.284120410833375118129
Urol298620410834364101117
praxi.31192041083386093124140153
2021;22(3):125-132.328720410833469101133141176211228262279291321351385407438468501513
19.21382140085366982
Herbison223621410834479100140156182220258
P,251021410833539
McKenzie256521410835486121156194223239273
J.285421410832436
Which290521410835896112143181
anticholinergic31022141083316991106138176214230245283318339378393425
is354221410831441
best359821410833874101124
for37372141083185678
people213822410833975115155172207
with23612241083577396135
overactive251122410834376111133166199224240273308
blades?28352241083446193133169196222
A3072224108347
network313522410834379102156194217248
meta-analysis.339922410836399122155178211250283299331359374401415
Neurourol213823410834580117139176214235272288
Urodyn.244223410834364102141173212225
2019;38(2):525-534.268223410833569100131143178213232266284296331364399421455488523536
20.21382440085367388
Nakagomi224324410834780111145185224283299
H,255824410834659
Mitsui26332441083577396124162178
T,282724410833544
Shimura28872441083357389147186208241
H,314424410834660
et322024410833659
al.32952441083345063
Mirabegron33742441083577395128168205245267305344
for37342441083205881
overactive213825410833770106128162195220236270305
bladder24592541083456295135175211233
in270825410832160
frail2784254108324488298114
patients291425410834579101117153192215243
80317425410834076
years326625410833773105127156
or343825410834366
over352025410834376111134
(HOKUTO367025410832470119213826410833580115162
study).23162641083305492132165183195
BMC252726410833995136
Urol.267926410834769106123137
2022;22(1):40.283226410833772106141154190225243276291303338375388
doi:32362641083428197110
10.1186/s12894022-00989-7.33622641083376982114142174210236261292322357392428213827410833468103124162199235271306330362369
21.21382840085367082
Staskin22352841083385992119148165203
D,245328410835162
Frankel25302841083375790128158193208
J,275428410832941
Varano28102841083417294127165203
S,302828410833851
et309428410833962
al.31712841083375265
International-phase32522841083195879113134173205227242280319351367389429468500527562
III,2138294108315304558
randomized,22112941083255896135173231246275309349362
doble258829410834280119135170
blind,27732941083435974111150163
placebo29512941083435991123157196235
and320129410833574113
active33292941083356792107139174
controlled351829410833572110132153190206221256296
study21383041083264987126158
to231230410832359
evaluate238730410833567100116153185207241
the26433041083236196
safety27553041083276079114136170
and294030410833371110
efficacy3066304108335537189121154186220
of330130410833858
vibegron33743041083334988123163184221260
in364930410831654
patients37183041083407321383141083223772110132160
with23143141083557194132
symptoms246231410833164123162184222280307
of278431410834362
overactive286231410834275109130164196220236269303
bladder:31813141083446092131171206227241
EMPOWUR.343831410833793129177235280316331
J3784314108330
Urol.213832410834465102118131
2020;204(2):316-324.228432410833468101135148183217254273307325337372403434458490522554567
22.21383340085367288
Marenčák224233410835386107141179211244274
J.253133410832335
Erektilná25823341083315286116140156171209241
dysfunkcia28383341083376996116154192223254269301
a3154334108330
jej32003341083134863
liečba.3279334108313286295134167180
Praktické34753341083335487117141157189219253
lekárnictvo.37433341083134821383441083306384123138170194228266279
2017;7(2):53-57.243234410833468100129139172188222240252287320342376410416
23.21383540085367287
Pattanaik22413541083366890114147185217232262
S,251835410833346
Mavuduru258035410835487119157196234255293
R,288835410833650
Panda295335410833668106145177
A,314635410834155
et321735410833456
al.32893541083324760
Phosphodiesterase33653541083357311113817721525329330834337039342621383641083215480115
inhibitors22693641083185694109148163186223244272
for25563641083226081
lower265336410831856107142163
urinary28313641083416278116148169203
tract30493641083264780112136
symptoms320136410833062121160182219277304
consistent352036410833572110136151177201234272294
with21383741083516689127
benign228037410834277115131169207
prostatic250337410834163100127150183205220252
hyperplasia.277037410834171111147168208224256283297329343
Cochrane312837410834380113151172205243278
database34213741083417495128167200227262
Syst36983741083366693116
Rev.213838410833570103113
2018;11(11):CD010060.226638410833468100131143173201216248275290302343388424456487523559595607
24.21383940085367186
Russo224039410833876102129167
G,242339410834660
Scandura249839410833568100138177215236269
C,278239410834356
Di285339410834964
Mauro293239410835890128149186
M,313439410835770
et322039410833659
al.32943941083355063
Clinical33723941083435873111126158191206
efficacy3593394108337567391123156188222
of213840410833756
Serrenoa22104041083306586108142180218251
repens24764041083195392127165192
versus26834041083296385112149175
placebo28744041083365284116150189228
versus31174041083296385112149175
alpha-blockers33084041083294483122154176216232270303333367388415
for37394041083165375
the21384141083226095
treatment22484141083204276108129188223261282
of254641410833555
lower261641410831351103137158
urinary27904141083355672110142163197
tract30034141083204174106131
symptoms/benign314941410832557116155177214272299324365400438453492530
prostatic3694414108338599621384241083264982104119151
enlargement:23044241083316985117138176211269304342363376
a2696424108329
systematic27404241083245683106140198230252267299
review30544241083185285100135186
amd325542410833087126
network33964241083367193146183205235
meta-364742410835589112144167
-analysis21384341083215391123139171198212239
of239243410833554
randomised24624341083195290129167225240266301341
placebo-contolled28184341083375385117151190229252286323361383420436451486525
clinical3358434108330456098113145178193
trials.3566434108320425789105131144
Eur37254341083316889
Urol213844410834465102118
Foc.227144410833370103116
2021;7(2):420-431.240244410833468101133141174190224242254288321355379415448479488
25.21384540085367287
Nagasubramanian224145410834577116148175212251273306364396434449481519
S,277645410833245
John283645410832462101139
N,299045410834457
Antonisami306345410834079100137175191217250308323
B,340145410833548
et346445410833456
al.35364541083314759
Tamsulosin3611454108332601181441812138464108315538095132
and228646410833270109
placebo24104641083395587119153192231
vs.26564641083325972
tamsulosin274446410832254112139176191229256271309
and306846410833270109
tadalafil31924641083225594126142174191208223
in343146410831452
male349946410835789105140
lower365446410831553104139160
urinary21384741083375873111143164198
tract23514741083194073105129
symptoms:249547410832456114153175212270296308
a2819474108329
double-blinded,286347410833673111150166200223263279294331370405444457
randomised33354741083185188127165223238264299338
controlled3688474108329651042138484108322438096111146186
trial.2339484108322435991106119
BJU247348410833660105
Int.2593484108315537487
2020;125(5):718-724.269648410833468101135148178208243260294312324358390421444475509541554
26.21384940085367187
De224149410834884
Nunzio234049410834785123152168206
C,256149410834356
Salonia26324941083356883121160175207
A,285449410834458
Gacci292749410834779111142157
M,310049410835770
et318649410833658
al.32604941083345062
The333849410833574109
role34624941083246177112
of358949410834059
combination36634941083347112921385041083395593126148163202241
therapy239450410832766101123156196227
with26375041083567294133
alpha-blockers27865041083375292131163186227243281314345379401428
and323050410833776115
hexanic336150410834378110143182197229
extract36065041083397196117151183208
Serenoa21385141083336889123162200233
repens23875141083266099135173200
in260251410832058
the267551410832766101
treatment27915141083274983115137195230268290
of309751410834261
LUTS/BPH.317451410833779114147173209245290303
J3492514108330
Clin35375141083456176114
Med.366651410836095135148
2022;11(23):7169.213852410833468101136148178206221255290307319352385416450461
doi:26145241083387692104
10.3390/jcm11237169.27335241083346678114147180216240256288346376404434469501533564598609
27.3934740085367079
Roehrborn40287410833371106144165204243264303
C,43467410833750
Oyarzabal44117410834477109130161194233265281
I,47077410831225
Roos47477410833270109135
E,48977410833043
et49557410833254
al.5024741083294457
Efficacy509674108330486583115148180213
and53247410832967105
safety5445741083235675109131164
of39348410833757
a400684108334
fixed-dose4055841083193667101141163203242268303
combination43748410833370128167183221253275290328367
of47568410833959
dutasteride48308410834078100133160183217238253292327
and51738410833372111
tamsulosin52998410832456114141178193231258273311
treatment3934941083224377109131189224262284
(Duodart®)42339410831662100139178210232256286304
compared45539410832966124163196217251291
with4859941083496487125
watchful49999410834881103134172191229245
waiting5259941083488196119134172211
with5485941083496487125
initiation3934104108315536890105137159174212251
of420010410833959
tamsulosin427410410832456114141178193231258273311
therapy46001041083246297118151190222
if483710410831736
symptoms488810410832861119159181218276302
do520610410834078
not529910410834078100
improve,54141041083177411413517239341141083326678
both402711410833978100138
provided41811141083396098129145184219259
with44551141083516689127
lifestyle4597114108316315084111134168184219
advice,483111410833372104120152186198
in504411410831553
the51121141083226196
management522311410835890128160199234292327365387
of393412410833757
treatment-naive40061241083244579111133191226264286305344377392424459
men448012410836095133
with46281241083536891129
moderately477212410836098138173194227249283298330
symptomatic511712410832961120159181218276309330346378
benign55101241083417739341341083385392130
prostatic408013410834365103129153186208223255
hyperplasia:435113410834273113149170210226259286300333345
2-year47111341083406092127159180
CONDUCT490713410834590136182227268304
study52261341083325593132164
results.54061341083266087124140162190204
BJU393414410833560104
Int.4054144108314527487
2015;116(3):450-459.415714410833468100130140170198229248282299311345378412436473506538549
28.39341540085367288
Kaplan403715410833569108124156194
S,424715410833245
Lee430715410833266101
J,442415410832436
Meehan447515410835590125164196234
A,472415410834155
et479515410833456
al.48661541083324861
Time494215410833349107142
course510015410833168106127154189
of530515410833756
incident53771541083145284100138173211233
adverse393416410833272106141163191226
experiences417616410834072113149171187223262295329357
associated45481641083386593132165181214236270311
with48751641083567396135
doxazosin,502616410834483114147178216243258297310
finasteride53521641083234079112139163197219235393417410833873
and402217410833573112
combination414917410833572130169185223255277292330368
therapy45331741083246297119152191222
in477017410831856
men484117410836196134
with49901741083546992130
benign513517410834277116131169207
prostatic535817410834163100127150183205220252
hyperplasia:393418410833868108144165205221253279294326338
the42881841083215994
MTOPS439818410835488134170203
trial.4617184108321435890106119
J4751184108324
Urol.479018410834465102118131
2016;195(6):1825-1829.493618410833569100132144174204238256289307319349380414449471501532566600611
29.39341940085367285
Gong403519410834584122161
M,421119410835669
Dong429519410834685124163
W,447319410835868
Huang455619410834583115153192
G,476319410834558
et483719410833457
al.49091941083334861
Tamsulosin498519410833361119146183198236263278316
combined531619410833269127166182220255294
with39342041083516790129
solifenacin40782041083327187102122157195228261276315
versus44082041083387294122160186
tamsulosin461020410832760119146184199238265280319
monotherapy4944204108363102141180203241277298332372403
for53632041083246284
male546320410836396111147
lower393421410831553103138159
urinary41082141083355671109141162196
tract43192141083194073105129
symptoms:446321410832456115153175212270296309
a4787214108329
meta-analysis.483121410835590112145167199237269284316343357383397
Curr52432141083377495116
Med537421410835287126
Res55162141083326794
Opin.393422410834787102140153
2015;31(9):1781-1792.410322410833468100130141176207222254272284314343377408427458487521554566
30.39342340085367287
Burgio40372341083377496134149187
K,423923410833651
Kraus43052341083365891129155
S,447523410833446
Johnson453723410832563102140166204243
T,479523410833342
et485323410833457
al.49252341083334861
Effectiveness50012341083345372106139163178211245283318345372
of538823410833857
combined54612341083326912739342441083395492128167
behavioral411724410834479118150182198236257291306
and443824410833776115
drug456824410834365103142
therapy472624410832765100121155194225
for49672441083236183
overactive506524410834375109130164196220235268303
bladder53832441083446092131171206227
symptoms393425410832659117156179215274300
in424925410832058
men:432225410836297135147
a4485254108336
randomized45372541083255896135173232247276310349
clinical49022541083365166104119151184199
trial.5116254108327486496111124
JAMA525625410832868124166
intern54372541083205779113134173
Med.393426410835490129142
2020;180(3):411-419.409226410833468101135148178209244264297314326361391419437474504534545
31.39342740085366981
Kaplan403127410833670109125157195
S,424127410833346
Herschorn430327410834479101128160198236258297
S,461527410833346
McVary467627410835688124156177211
K,490227410833650
et496827410833457
al.50402741083334861
Efficacy5116274108334516987119152184218
and534927410833371110
safety54742741083276079113393428410832257
of400628410834464
mirabegron408528410836480102135176212253274312352
versus44532841083377294122160187
placebo46562841083456194127162202242
add-on491428410833878118140181220
therapy515028410832867103125158198231
in539728410832059
men5471284108364100139
with39342941083516689127
overactive407629410833668102123156189213228261295
bladder43862941083385386125164199220
symptoms462129410832557116155177214273299
receiving49352941083205486120135168184221260
tamsulosin521129410832053111137174190228254269307
for55342941083175476
underlyingbenign393430410833775113148169185216232270308347382420435474511
prostatic44613041083365794121144176198213244
hyperplasia:472130410833565105140161200216248274289321333
a5069304108329
randomized,51133041083195189128166224239267301341353
phase548130410833675107393431410832661
44010314108335
study40603141083264987126158
(PLUS).42333141083195586128160179190
J4438314108325
Urol.447831410834465102118131
2020;203(6):1163-1171.462431410833468101135148183217250268302320332361389420454476507534564596605
32.39343240085367186
Chen403632410834381116154
P,420532410833943
Wang426332410836192130169
Ch,44473241083438194
Tu455632410833669
Y.464032410833947
Combination470332410834279138177192230263284300338376
alpha50943241083355189128160
blocker52703241083415795128158192213
and549932410833472111
phosphodiesterase393433410833977115142181220258298313347374397431452485512547
54496334108338
inhibitor45493341083185694109148164186223245
versus48093341083356990118155181
alpha50063341083355089128160
blocker51813341083425896129159193214
monotherapy54113341083609913717539343441083226096117151190222
for41723441083236183
lower427134410832058110145166
urinary44533441083436480118151172207
tract46753441083274982115139
symptoms483034410833164124163186223282308
associated51543441083376491130163178211233267307
with54763441083567295134
benign393435410833974112127166204
prostate41543541083375895122145178200234
hyperplasia:440335410833667107142163203219251278293325337
a4755354108330
systematic48013541083245784107141199231253268300
review51163541083195486102136187
and531935410833068107
meta-544135410835691113146169
-analysis.39343641083215391123139171198212239252
Uro420236410834364101
Sci.4319364108332658093
2020;31(3):99-107.442736410833468101135148183214229263280292327362386417448481487
33.39343740085367186
Yamanishi403537410833665123156194209235273288
T,433837410833342
Asakura439537410834270103133171192225
H,463637410834457
Seki47083741083336899115
N,483837410834658
et491237410833456
al.49843741083324760
A5060374108341
52511637410833568
–5200374108335
week525037410835186121152
randomized54173741083215492131169393438410835874104139180
comparative413038410833775134175209230264287303336372
study45173841083325695135168
of470138410834363
a4780384108338
triple48343841083275066106123158
therapy500838410832867103125159199231
(tamsulosin,52553841083244680139166205220260287303341355
dutasteride,39343941083387698131158181214236251290325337
and428639410833775114
imidafenacin)44153941083197792131163182217255287319334372390
versus48203941083367092119156182
a5018394108336
dual506939410834381113128
therapy52133941083266499120153193224
(tamsulosin5452394108323447713539344041083266379117144158196
and414640410833169108
dutasteride)42694041083377598130157180214235251289324342
in462640410831452
benign469340410833874112127166204
prostatic49124041083386097124147180201217249
hyperplasia517640410833767107143164204220252278293325
patients55174041083387139344141083223771109131158
with41084141083486386124
overactive424741410833567101122155187211226259293
bladder45554141083375285124162197218
(DIrecT4789414108316627798132165193
Study).49984141083305189128159178188
Eur52024141083306687
Urol53054141083416299115
Suppl.543541410833068107146162175
2017;16(3):e924.393442410833468100129139169200219253270282317351384416429
34.39344340085367388
Khizer40384341083397994123157178
Z,423143410834255
Sadia430243410833669108123155
A,447343410834559
Sharma454743410833775107128186219
R,478143410834053
et485043410833860
al.49254341083365265
Drug500543410834971109148
delivery51694341083427792107140174195229
approaches541443410833575114136173393444410833264102137164
for41134441083215880
managing420844410836092130162201216254293
overactive451744410833971105126159192216231264298
bladder48304441083415789128167202223
(OAB):506944410832067106142160172
a5256444108334
systematic53064441083286087111144202235256272304
review.39344541083215587103137189199
Pharmaceuticals414945410833471104125183216248281319342357389422437463
(Basel).46284541083175386112147163182193
2021;14(5):409.483745410833367100131139169201220254272284318354389400
doi:52534541083377590102
10.3390/53714541083336477112145179214239
ph14050409.393446410833977107138174208242278314349360
35.39344740085367287
Peyronnet403847410834175107130168207246282305
B,435847410834255
Brucker442947410834163102135166200222
B,466747410834154
Michel473747410836177110148184200
M.495347410836175
Lower504447410833775127163184
urinary52444741083436581120153175209
tract54694741083285083116141
symptoms:393448410832659117156179215274300313
what´s426248410835391123145166189
new446648410834075126
in460748410831755
medical467748410836095134150181214230
treatment?49224841083244579111133191226264286311
Eur52494841083347192
Urol535648410834667105120
Foc.549248410833472104118
2018;4(1):17-24.393449410833468100131143178197229243255285315333364396408
36.39345040085367388
Belos40385041083417692131157
T,421150410833847
Tzelves42735041083386398113146180207
L,449650410833750
Manolitsis456250410836092131169185200223251266292
I,487050410832033
et491850410833962
al.49955041083375366
Frailty50765041083385891106122144178
and527050410833775114
benign540050410834479118133172210
prostatic39345141083396097124147180202217249
hyperplasia:419851410834273113149170210226258284299331343
the45575141083266499
thrilling46715141083266586101116132147184223
underlying491051410834179118153175190222238276315
impact.524051410831977116149181205219
Arch54745141083466798136
Ital3934524108315377085
Urol403552410834364101117
Androl.416852410834179118139176192205
2022;94(3):345-349.438852410833569102136149184220239273290302337373405428460495528539